Laekna, Inc. (HKG:2105)
Hong Kong
· Delayed Price · Currency is HKD 14.41
-0.65 (-4.32%)
At close: Apr 29, 2026
Laekna Market Cap
Laekna has a market cap or net worth of 6.06 billion as of April 29, 2026. Its market cap has increased by 25.93% in one year.
Market Cap
6.06B
Enterprise Value
4.79B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.41
Market Cap Chart
Since June 29, 2023, Laekna's market cap has increased from 5.85B to 6.06B, an increase of 3.57%. That is a compound annual growth rate of 1.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 6.06B | 6.78% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 6.16B |
| Jacobio Pharmaceuticals Group | 5.58B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Guangzhou Innogen Pharmaceutical Group | 7.27B |
| Beijing Luzhu Biotechnology | 4.57B |
| Shandong Boan Biotechnology | 4.29B |
| Shanghai Haohai Biological Technology | 9.40B |
| Abbisko Cayman | 9.43B |